FREE Case Review (866) 588-0600

Boehringer Supports Pradaxa MDL, Disagrees on Proposed Venue

In response to a recent motion filed by plaintiffs in an attempt to consolidate all federal Pradaxa internal bleeding lawsuits into a multidistrict litigation, drugmaker Boehringer Ingelheim has indicated that it is in favor of the move.

In response to a recent motion filed by plaintiffs in an attempt to consolidate all federal Pradaxa internal bleeding lawsuits into a multidistrict litigation (MDL), drugmaker Boehringer Ingelheim has indicated that it is in favor of the move, and supports centralizing the cases before one judge for pretrial coordination. 

Free Pradaxa Lawsuit Evaluation: If you or a loved one has been injured by Pradaxa, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the problem?

June 28, 2012 – The original petition to consolidate the Pradaxa internal bleeding lawsuits was filed last month on behalf of plaintiff Vera Lee Sellers. The request called for the cases to be transferred to U.S. District Judge David R. Herndon in the Southern District of Illinois, who recently oversaw the federal Yaz and Yasmin litigation.

In a formal response filed last week, Boehringer indicated that it fully supports Sellers’ proposed multidistrict litigation for the Pradaxa cases. MDLs are designed to reduce duplicative discovery, eliminate conflicting pretrial rulings from different judges, and to serve the convenience of all parties involved. Yet despite Boehringer’s willingness to comply with the consolidation, the company disagrees about where the cases should be sent.

Boehringer has asked that the Pradaxa MDL be centralized in the District of Connecticut, which is where the company’s corporate headquarters are located, and where the vast majority of the relevant documents, witnesses and parties common to all lawsuits are located. The U.S. Judicial Panel on Multidistrict Litigation (JPML) has set oral arguments on the formation of the Pradaxa MDL to begin July 26, at a hearing to be held at the Carl B. Stokes U.S. Courthouse in Cleveland, Ohio.

MDLs are common in complex pharmaceutical litigation, where a large number of lawsuits are filed involving similar allegations of fact. Although the cases in an MDL are handled in a coordinated manner, unlike class action lawsuits, each claim remains an individual case. In the event that a settlement is not reached or other suitable resolution not attained, the cases are remanded back to the original district where they were filed for individual trial dates.

Do I Have a Pradaxa Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Pradaxa lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.

Free Confidential Case Evaluation: Again, if you or a loved one was injured by Pradaxa, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition